2026险资寻“牛”记权益策略将更趋精细化

Core Insights - The insurance capital market has seen significant activity in 2025, with the highest number of stake acquisitions in a decade and a substantial increase in investments in dividend assets, making insurance capital a key shareholder in many popular tech stocks [1] - In 2026, insurance capital is expected to adopt a more cautious and refined investment strategy, shifting from a focus on overall market elasticity to selecting individual stocks and sectors for excess returns [1][3] - The core variables driving increased equity investment by insurance capital include the macro interest rate environment, policy guidance, and liability-side demand, which are anticipated to continue catalyzing the allocation towards equity assets [2][3] Investment Strategy Adjustments - The investment strategy for 2026 will be more prudent and precise, adapting to the market's transition from valuation-driven to profit-driven dynamics, with a focus on high-dividend assets as a stabilizing factor [3][4] - The dynamic adjustment of equity positions will become more flexible and refined, with an emphasis on structural optimization and close monitoring of market liquidity and corporate profit recovery [4] - The overall strategy for equity investments will prioritize cash flow stability, dividend reliability, and visible profitability, while trading strategies will focus on sectors with rapid profit realization potential [3][4] Key Investment Themes - Insurance capital is expected to focus on investment opportunities arising from China's economic transformation and upgrading, particularly in sectors with genuine technological barriers and clear business models [4][6] - Six major investment themes have been identified: artificial intelligence, "anti-involution" policies, high-value exports, cyclical domestic demand, energy and commodities, and the trend of renminbi appreciation [6] - The emphasis will be on sectors such as AI, advanced manufacturing, and industries with high growth potential, including robotics, quantum computing, and innovative pharmaceuticals [5][6]